Explore Our Biomarker Menu

Biomarker:

Calbindin

Biological or Clinical Significance:

Calbindin (Calbindin D-28K) is a member of the calbindin family which are calcium binding proteins belonging to the troponin C superfamily. They were originally described as vitamin D-dependent calcium-binding proteins in the intestine and kidney in the chick and mammals. They are now classified in different sub-families as they differ in the number of Ca2+ binding EF-hand sites.

Calbidin is expressed in the kidney, pancreatic islets, and brain. Neurons in the brains of patients with Huntington disease are calbindin depleted. There are two types of CaBPs: the “trigger”- and the “buffer”-CaBPs. The conformation of “trigger” type CaBPs changes upon Ca2+ binding and exposes regions of protein that interact with target molecules, thus altering their activity. The buffer-type CaBP is thought to control the intracellular calcium concentration. Calbindin D-28K is found predominantly in subpopulations of central and peripheral nervous system neurons, certain epithelial cells involved in Ca2+ transport such as distal tubular cells and cortical collecting tubules of the kidney, and in enteric neuroendocrine cells.

References:

Analyte:

Calbindin

Matrix:

Status:

Experienced Running

Sensitivity-LLOQ:

Sensitivity-ULOQ:

platform

MSD-ECL

Required Sample Volume

Disease State:

MSD Panel:

Speak To A Scientist





    I consent to receive communications (which may include, phone, email, social, and re-targeting ads) from BioAgilytix. I understand I may proactively manage my preferences or opt-out of communications with BioAgilytix at any time using the unsubscribe link provided in all of BioAgilytix’s email communications and can learn more by reading the privacy policy.

    Immunogenicity

    Learn why BioAgilytix is a world-leading authority on immunogenicity studies related to ADA, NAb assay development and validation, isotyping, and more.

    Case Studies

    Learn why we’re a trusted partner to 22 of the top 25 global pharma and biotech companies.